Chalmers Group buys Blue Sage-backed Primus Sterilizer

Chalmers Group of Companies has acquired Primus Sterilizer Co LLC, an Omaha, Nebraska-based maker of steam sterilizers used in laboratories, hospitals and pharmaceutical companies.

No financial terms were released for the deal, which closed earlier this month.

In a separate release, Chalmers, a Mississauga, Ontario-based products supplier to the medical and transportation equipment industries, said Primus will be added to its affiliates Scientek and CSI Jewett.

The transaction provided an exit to U.S. private equity firm Blue Sage Capital, which invested in Primus in 2006.


Blue Sage Exits Final Fund I Portfolio Company, PRIMUS Sterilizer

November 20, 2018

Blue Sage Capital announced today that it closed on the sale of PRIMUS Sterilizer Company, LLC (“PRIMUS” or the “Company”) to the Chalmers Group of Companies, a privately-owned Canadian corporation headquartered in Mississauga, Ontario. The sale represents the thirteenth and final portfolio company exit for Blue Sage’s first fund, Blue Sage Capital, L.P.

Based in Omaha, Nebraska, PRIMUS is the leading independent manufacturer of steam sterilizers in the United States. The Company’s sterilizers can be found in premier research laboratories, hospitals and pharmaceutical companies throughout the world.

PRIMUS and Blue Sage were represented in the transaction by Livingstone Partners LLC and Queen Saenz + Schutz PLLC.

About Blue Sage

Blue Sage is an Austin, Texas-based private equity firm specializing in growth, recapitalization and buyout financings of small middle market companies. With over fifteen years as a team and over $200 million in assets under management, Blue Sage has extensive experience transitioning founder-run businesses and seeks companies with leadership positions in their niche markets. Most of Blue Sage’s investments are in established, profitable companies with $20 million to $100 million of revenue and $4 million to $12 million of cash flow. Blue Sage invests in a variety of industries, with each initial investment typically ranging from $10 million to $40 million.

For questions or inquiries, please contact Peter Huff at 512-536-1900 or email